The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- FG inaugurates financial and digital monitoring system for SAPZ
- NADF receives N3.4m surplus from Jaiz Takaful
- FAAN to temporarily close Owerri airport runway for repairs
- Transport major obstacle for farmers – Ali
- CBN deepens Asia ties to boost Nigeria’s financial markets
- TCF calls for end to child marriage in Nigeria
- CS-SUNN launches media plan to boost nutrition financing in Kaduna
- NOA urges regular eye checks
